Title : MicroRNA-221 promotes breast cancer resistance to adriamycin via modulation of PTEN/Akt/mTOR signaling.

Pub. Date : 2020 Feb

PMID : 31899608






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 MicroRNA-221 promotes breast cancer resistance to adriamycin via modulation of PTEN/Akt/mTOR signaling. Doxorubicin phosphatase and tensin homolog Homo sapiens
2 Taken together, these findings suggest microRNA-221 suppresses PTEN transcription and activates Akt/mTOR pathway, which in turn enhances breast cancer resistance to adriamycin and promotes cancer development. Doxorubicin phosphatase and tensin homolog Homo sapiens